11β-羟基类固醇脱氢酶 (11β-HSD) 的两种同工酶催化活性皮质醇和皮质酮与惰性皮质酮和 11-脱氢皮质酮的相互转化。11β-HSD 1 型 (11β-HSD1) 是大多数完整细胞中的主要还原酶,可催化活性糖皮质激素的再生,从而增强细胞作用。11β-HSD1 在肥胖的脂肪组织中选择性升高,导致代谢并发症。同样,11β-HSD1 在衰老的大脑中升高,加剧糖皮质激素相关的认知衰退。11β-HSD1 的缺乏或选择性抑制可改善啮齿动物模型和人类临床试验中的多种代谢综合征参数,并同样改善衰老过程中的认知功能。11β-HSD2 是一种高亲和力脱氢酶,可灭活糖皮质激素。在远端肾单位中,11β-HSD2 可确保只有醛固酮是盐皮质激素受体 (MR) 的激动剂。11β-HSD2 抑制或遗传缺陷会导致明显的盐皮质激素过量和高血压,这是由于肾 MR 的糖皮质激素激活不当造成的。胎盘和胎儿也高度表达 11β-HSD2,通过灭活糖皮质激素,可防止胎儿组织过早成熟以及随之而来的发育“编程”。
Two isozymes of 11β-hydroxysteroid dehydrogenase (11β-HSD) catalyze interconversion of active cortisol and corticosterone with inert cortisone and 11-dehydrocorticosterone. 11β-HSD type 1 (11β-HSD1), a predominant reductase in most intact cells, catalyzes the regeneration of active glucocorticoids, thus amplifying cellular action. 11β-HSD1 is selectively elevated in adipose tissue in obesity where it contributes to metabolic complications. Similarly, 11β-HSD1 is elevated in the ageing brain where it exacerbates glucocorticoid-associated cognitive decline. Deficiency or selective inhibition of 11β-HSD1 improves multiple metabolic syndrome parameters in rodent models and human clinical trials and similarly improves cognitive function with ageing. 11β-HSD2 is a high-affinity dehydrogenase that inactivates glucocorticoids. In the distal nephron, 11β-HSD2 ensures that only aldosterone is an agonist at mineralocorticoid receptors (MR). 11β-HSD2 inhibition or genetic deficiency causes apparent mineralocorticoid excess and hypertension due to inappropriate glucocorticoid activation of renal MR. The placenta and fetus also highly express 11β-HSD2 which, by inactivating glucocorticoids, prevents premature maturation of fetal tissues and consequent developmental “programming.”
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号